☆ 4.7 Article

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Rheumatology

Acute exacerbation of interstitial lung disease associated with rheumatic disease

Fabrizio Luppi et al.

Summary: This review summarizes the clinical features, diagnosis, management, and prognosis of acute exacerbation of interstitial lung disease in patients with rheumatic diseases. It highlights the lack of specific definition and evidence-based therapeutic strategies for this condition, underscoring the need for further research and development in this area.

NATURE REVIEWS RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents

Vincenzo Venerito et al.

Summary: Machine learning models can be used to predict sustained remission in rheumatoid arthritis patients on biologic disease-modifying antirheumatic drugs (bDMARDs). The method relies on a few easy-to-collect patient attributes.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg et al.

Summary: In this trial comparing the use of tofacitinib with a TNF inhibitor in a cardiovascular risk-enriched population, the risks of major adverse cardiovascular events (MACE) and cancers were found to be higher with tofacitinib, and it did not meet noninferiority criteria. Several adverse events were more common with tofacitinib.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Review Medicine, General & Internal

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review

Antonella Laria et al.

Summary: Rheumatoid arthritis is a systemic disease that not only affects the joints but also commonly involves the lungs. Pulmonary disease is a major contributor to RA-related deaths, accounting for a significant percentage of overall mortality. However, optimal screening, diagnostic, and treatment strategies for pulmonary disease in RA patients remain uncertain, and further investigation is needed.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Respiratory System

Methotrexate and rheumatoid arthritis associated interstitial, Lung disease

Pierre-Antoine Juge et al.

Summary: The study found that there is no increased risk of RA-ILD associated with MTX use in patients with RA, and that ILD was detected later in MTX-treated patients.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Rheumatology

Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients Post Hoc Analysis From 21 Clinical Trials

Gustavo Citera et al.

Summary: The study showed that the incidence rates of ILD events in RA patients treated with tofacitinib were low, and were associated with factors such as age, smoking, and disease activity score.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Review Immunology

Rheumatoid arthritis related interstitial lung disease

Andreina Manfredi et al.

Summary: Rheumatoid arthritis-related interstitial lung disease is a common extra-articular manifestation that significantly impacts patients' quality of life and overall prognosis, necessitating early diagnosis and treatment. High-resolution computed tomography is the gold standard for ILD diagnosis, but determining the correct therapeutic strategy remains challenging due to the high variability of clinical presentation and disease progression. A multidisciplinary approach involving rheumatologists, pulmonologists, and radiologists is currently recommended to define optimal therapy and follow-up strategies.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Liana Fraenkel et al.

Summary: The guideline provides updated recommendations for the pharmacologic management of rheumatoid arthritis, including the use of DMARDs, glucocorticoids, and their use in certain high-risk populations. It consists of 44 recommendations and aims to support clinician and patient decision-making processes.

ARTHRITIS CARE & RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis

Caterina Vacchi et al.

Summary: Rheumatoid arthritis is a chronic inflammatory disease with systemic manifestations, including interstitial lung disease, which poses treatment challenges. Tofacitinib may be a safe therapeutic option for patients with RA-ILD, effectively controlling joint involvement, stabilizing ILD, and improving respiratory symptoms. Longitudinal studies are needed to confirm the promising results.

CASE REPORTS IN MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis

Annalisa Fui et al.

INTERNAL MEDICINE JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study

Andreina Manfredi et al.

INTERNAL MEDICINE JOURNAL (2020)

添加到收藏夹

Article Rheumatology

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

Cristina Vadillo et al.

RHEUMATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study

Giulia Cassone et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Rheumatology

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Christopher R. Holroyd et al.

RHEUMATOLOGY (2019)

添加到收藏夹

Review Respiratory System

Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature

Andreina Manfredi et al.

JOURNAL OF THORACIC DISEASE (2019)

添加到收藏夹

Review Rheumatology

A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis

Vincenzo Venerito et al.

CLINICAL RHEUMATOLOGY (2019)

添加到收藏夹

Article Rheumatology

Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice

Sho Sendo et al.

ARTHRITIS RESEARCH & THERAPY (2019)

添加到收藏夹

Article Critical Care Medicine

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

添加到收藏夹

Review Rheumatology

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

Roberto Perez-Alvarez et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)

添加到收藏夹

Article Rheumatology

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

W. G. Dixon et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

添加到收藏夹

Article Rheumatology

2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Daniel Aletaha et al.

ARTHRITIS AND RHEUMATISM (2010)

添加到收藏夹

Article Rheumatology

Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

J Ledingham et al.

RHEUMATOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.